Is myotonic dystrophy a single-gene disorder?

1996 ◽  
Vol 24 (2) ◽  
pp. 510-513 ◽  
Author(s):  
K. J. Johnson ◽  
C. A. Boucher ◽  
S. K. King ◽  
C. L. Winchester ◽  
M. E. S. Bailey ◽  
...  
1996 ◽  
Vol 6 (2) ◽  
pp. S18
Author(s):  
K.J. Johnson ◽  
C.A. Boucher ◽  
S.K. King ◽  
C.L. Winchester ◽  
M.E.S. Bailey ◽  
...  

Blood ◽  
2002 ◽  
Vol 100 (13) ◽  
pp. 4255-4255
Author(s):  
George J. Dover

2020 ◽  
Vol 8 (8) ◽  
Author(s):  
Alice Traversa ◽  
Enrica Marchionni ◽  
Agnese Giovannetti ◽  
Maria L. Genovesi ◽  
Noemi Panzironi ◽  
...  

The Lancet ◽  
2000 ◽  
Vol 356 (9236) ◽  
pp. 1170 ◽  
Author(s):  
Hiroshi Saito ◽  
Akihiko Sekizawa ◽  
Taro Morimoto ◽  
Makoto Suzuki ◽  
Takumi Yanaihara

Author(s):  
Jeremy Fairbank

♦ Neurofibromatosis type 1♦ Single gene disorder♦ Serious scoliosis♦ Pseudoarthrosis of a long bone♦ Hypertrophy of a part♦ An unusual radiographic lesion of bone.


Author(s):  
Dan Ehninger ◽  
Alcino J. Silva

Tuberous sclerosis (TSC) is a single-gene disorder caused by heterozygous mutations in either the TSC1 or TSC2 genes (Consortium, 1993; van Slegtenhorst et al., 1997). In 70% of cases, TSC gene mutations arise de novo. The remaining 30% of cases are familial with an autosomal dominant pattern of inheritance. Tuberous sclerosis belongs to the group of phakomatoses (neurocutaneous disorders) and is associated with characteristic manifestations in various organ systems, including the brain, skin, kidney, lung, heart, and liver (Crino, Nathanson, & Henske, 2006; Curatolo, Bombardieri & Jozwiak, 2008). Pathological manifestations in these organ systems often include tumor growths or tissue malformations (hamartomas). While penetrance is high, expressivity of TSC phenotypes is highly variable. The birth incidence of TSC is approximately 1:6,000 (Osborne, Fryer, & Webb, 1991). This chapter is an updated and extended version of a previous article on this topic (Ehninger, de Vries, & Silva, 2009)


Sign in / Sign up

Export Citation Format

Share Document